The Dawn of a New Era in Heart Failure Treatment: BioCardia’s CardiAMP Heart Failure II Phase 3 Pivotal Study February 8, 2024 Read More »
Coeptis Therapeutics Advances with Groundbreaking Stem Cell Therapy in Phase 2 Program February 7, 2024 Read More »
Mirus Bio Achieves ISO 13485:2016 Certification: A Milestone in Quality Management January 31, 2024 Read More »
